Depression meets obesity: Co‐occurrence patterns, temporal trends and socioeconomic correlates across 199 countries and territories Authors: Yang Yang, Jingqi Kong, Jing Chen, Yihang Yang, Jingyao Liu, Runze Hu, Dexing Zhang, Zheng Liu Published: 2026 ABSTRACT ABSTRACTBackgroundDepression and obesity are major global health burdens, yet the co‐occurrence patterns and temporal trends of their comorbidity remain poorly characterised at the global level.AimsTo map the global patterns of co‐occurring depression and obesity, quantify temporal trends of depression, obesity and comorbidity, forecast the prevalence of comorbidity up to 2035 and compare social indicators across groups stratified by their combined temporal trends of depression and obesity.MethodsData were sourced from the Global Burden of Disease Study 2023, the NCD Risk Factor Collaboration and the World Bank Open Data repository. Countries and territories (n = 199) were classified into four co‐occurrence patterns based on the current prevalence of depression and obesity. Average annual percentage changes (AAPCs) were calculated to quantify temporal trends and define four trend groups. We forecast the prevalence of depression–obesity comorbidity across 199 countries and territories up to 2035 using an autoregressive integrated moving average model. The Kruskal–Wallis H test and Mann–Whitney U test were used to compare seven social indicators relevant to socioeconomic status and healthcare resources across these trend groups.ResultsFor the four co‐occurrence patterns, the consistently‐low‐prevalence group was primarily concentrated in Asia, the consistently‐high‐prevalence group in the Americas, the depression‐dominant group in Africa and the obesity‐dominant group in the Americas and Oceania. Concerning temporal trends, the prevalence of depression–obesity comorbidity increased globally (median AAPC: 4.66%; interquartile range [IQR]: 3.49%–6.30%). Notably, countries and territories in East Asia, Southeast Asia and sub‐Saharan Africa had higher comorbidity AAPCs despite their low current prevalence. Temporal trends were categorised into four patterns: 44 (22.11%) countries and territories were classified into the double‐fast‐growing group (Southeast Asia, sub‐Saharan Africa), 56 (28.14%) into the depression‐driven‐growing group (West Asia, North Africa, North America, Oceania), 56 (28.14%) into the obesity‐driven‐growing group (East Asia, Latin America and the Caribbean) and the remaining 43 (21.61%) into the double‐slow‐growing group (Europe, Australia and New Zealand). Predictive analysis indicated the median prevalence of depression–obesity comorbidity may increase to 833.32 (IQR: 532.07–1367.42) per 100 000 in 2030 and 869.35 (IQR: 544.11–1403.71) per 100 000 in 2035. Compared with the double‐slow‐growing group, the obesity‐driven and double‐fast‐growing groups showed poorer socioeconomic status and healthcare resources; the depression‐driven‐growing group showed poorer healthcare resources.ConclusionsThe prevalence of depression–obesity comorbidity increased globally. Particular attention is warranted for countries and territories with currently low comorbidity prevalence but rapidly increasing trends. Our findings also highlight the need for accessible interventions for countries and territories with poorer socioeconomic status and healthcare resources.Keywords: comorbidity, depressive disorder, Global Burden of Disease, obesity INTRODUCTION Depression and obesity are among the most prevalent public health challenges, affecting both mental and physical health globally. An estimated 320 million people experience depression worldwide, whilst obesity affects approximately one billion individuals. 1 , 2 Depression–obesity comorbidity has become increasingly prevalent, underpinned by a bidirectional association 3 , 4 and shared risk factors. 5 , 6 This comorbidity not only compounds the health burden but also challenges the effectiveness of conventional public health interventions that focus on a single condition. 7 , 8 Characterising global depression–obesity comorbidity patterns and temporal trends is critical for public health surveillance. Epidemiological evidence supports a bidirectional link, 9 suggesting that countries and territories with a high prevalence of either condition face heightened comorbidity risk. Depression is associated with elevated body mass index (BMI), 10 , 11 potentially mediated by behavioural risk factors such as emotional eating, 12 , 13 sedentary behaviour 14 and insufficient sleep. 15 , 16 The rising global prevalence of these behavioural risk factors 17 , 18 , 19 underscores the need to monitor the pathway from depression to obesity and, ultimately, to their comorbidity. Conversely, obesity increases the risk of depression through weight stigma, 20 body dissatisfaction 21 and weight‐based victimisation. 22 , 23 Given geographical and cultural heterogeneity, 24 countries and territories with a high or rapidly rising obesity prevalence warrant particular attention for emerging depression–obesity comorbidity. Mapping comorbidity patterns and their trajectories, alongside modifiable socio‐environmental indicators, may inform surveillance priorities and integrated policy formulation. Social environment indicators have a substantial impact on depression–obesity comorbidity 25 , 26 , 27 and the effectiveness of policy interventions in improving population health has been widely recognised. 28 , 29 , 30 A focus on individual‐level determinants alone may overlook national‐level, modifiable socio‐environmental factors relevant to the management of obesity, depression and their comorbidity. Evidence supports the implementation of educational, regulatory and legal initiatives to reduce weight stigma. 24 Moreover, existing single‐country studies 31 , 32 , 33 , 34 , 35 may not capture the compounding effects of globalisation. Globalisation has increased cross‐cultural exposure, 36 which may influence dietary choices, 37 body perception 38 and other health‐related behaviours. Therefore, a global mapping of comorbidity trends and social determinants is urgently needed to inform policies aimed at improving population health. 39 , 40 , 41 To address these research gaps, we analysed country‐level data from the Global Burden of Disease (GBD) study and the NCD Risk Factor Collaboration (NCD‐RisC) to characterise global depression–obesity comorbidity patterns. Our objectives were to: (1) map global co‐occurrence patterns of depression and obesity; (2) quantify temporal trends in depression, obesity and their comorbidity using average annual percentage changes (AAPCs); (3) forecast the prevalence of depression–obesity comorbidity across 199 countries and territories up to 2035 using an autoregressive integrated moving average (ARIMA) model; and (4) compare social indicators across country groups defined by combined depression–obesity temporal trends. METHODS Data sources This study derived information mainly from three sources: the GBD, NCD‐RisC and the World Bank. The GBD study adheres to the Guidelines for Accurate and Transparent Health Estimates Reporting and provides the prevalence of depression at the global, regional and national levels since 1990. 42 The definition of depression in the GBD framework is based on criteria from the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision and the International Classification of Diseases and Related Health Problems, Tenth Revision. 43 , 44 From the GBD, we obtained the age‐standardised prevalence of depression for children (aged 5–19 years) and adults (aged 20–95 years), stratified by sex. The NCD‐RisC provides population‐based, high‐quality data on obesity prevalence at the country level from 1957 to 2022. 26 , 45 , 46 The NCD‐RisC defines obesity as a BMI of 30 kg/m2 or higher for adults and childhood obesity as a BMI more than two standard deviations above the age‐ and sex‐specific median. 26 We obtained the age‐standardised, sex‐specific prevalence of obesity for adults (aged ≥ 20 years) and children (aged 5–19 years). We also obtained the Socio‐Demographic Index 47 (SDI) from the GBD and other related risk factors from the World Bank, including the prevalence of undernourishment, the Gini index (GINI), the gross national income per capita (Atlas method) (GNI), female and male unemployment rates and hospital beds per 1000 people. Details of these indicators are provided in Supplementary I. We excluded five countries and territories with prevalence data for only one of the two conditions, ultimately including 199 countries and territories with complete data on both conditions (figure 1). Flowchart of data inclusion from the Global Burden of Disease, the NCD Risk Factor Collaboration and the World Bank. GINI, Gini index. Statistical analysis After calculating the age‐standardised prevalence of obesity for all populations using data from NCD‐RisC (see Supplementary II for details), we categorised the 199 countries and territories into four co‐occurrence pattern groups based on the current prevalence quartiles of both conditions. The prevalence quartiles were defined as low (< 25th percentile), lower‐middle (25th–50th percentile), upper‐middle (50th–75th percentile) and high (> 75th percentile) quartiles. The countries and territories were then categorised as the “consistently‐low‐prevalence” group if the prevalence quartiles of both conditions fell within the low or lower‐middle quartile and the “consistently‐high‐prevalence” group if both fell within the upper‐middle or high quartile. They were classified as the “depression‐dominant” group if depression prevalence was in the upper‐middle or high quartile, but that of obesity was in the low or lower‐middle quartile. Conversely, they were categorised as the “obesity‐dominant” group if obesity prevalence was in the upper‐middle or high quartile, but that of depression was in the low or lower‐middle quartile. To estimate the prevalence of depression–obesity comorbidity, we applied the formula P = ρ × P 1 × P 2 and ρ=1+r×k (P 1 and P 2: the respective prevalence rates of the two conditions, ρ: the strength of association between the two conditions; r: the Pearson correlation coefficient estimated by the GBD and the NCD‐RisC; k: an empirical coefficient that adjusts the strength of association). 48 , 49 In the primary analysis, we used the k value of 0.5 and four alternative k values of 0.2, 0.4, 0.6 and 0.8 in sensitivity analyses. We used Joinpoint regression to calculate the AAPC and quantify temporal trends in depression, obesity and their comorbidity among girls, boys, women, men and the overall population (see Supplementary II for details). After standardising the AAPCs of all populations using the Max–Min approach, we divided the 199 countries and territories into four groups: (1) double‐fast‐growing group: standardised AAPCs of both conditions were above the median; (2) double‐slow‐growing group: standardised AAPCs of both conditions were below the median; (3) depression‐driven‐growing group: standardised AAPC of depression was above the median whilst that of obesity was below the median; and (4) obesity‐driven‐growing group: standardised AAPC of obesity was above the median whilst that of depression was below the median. In addition, we used an ARIMA model to forecast the prevalence of depression–obesity comorbidity across 199 countries and territories up to 2035 (see Supplementary II for details). The AAPC of depression and obesity in different groups was analysed by Joinpoint Software (version 5.3.0). The remaining analyses and visualisations were conducted using Python (version 3.12.8). RESULTS Current co‐occurrence patterns of depression and obesity Overall, the global prevalence of obesity in 2022 substantially exceeded that of depression in 2023, with a median prevalence of 18 891.43 and 3680.42 per 100 000 for obesity and depression, respectively. The spatial distributions of obesity and depression prevalence showed similar quartile patterns across the 199 countries and territories. A total of 41 countries and territories (20.60%) had consistent prevalence levels for both conditions within the same quartile band, comprising 22 (11.06%) low‐low and 19 (9.55%) high‐high quartile groups. The consistently‐low‐prevalence group was primarily concentrated in Central, East and Southeast Asia, whilst the consistently‐high‐prevalence group was in West Asia, North Africa and the Americas. The remaining countries and territories showed either an obesity‐dominant or depression‐dominant pattern, accounting for 26.63% and 26.13%, respectively. Countries and territories in North America, Eastern Europe and Oceania showed a predominance of obesity, whilst those in South Asia, Western Europe and sub‐Saharan Africa exhibited a depression‐dominant pattern (figure 2, Supplementary figure S1). Global distribution of the current prevalence of depression (A) and obesity (B) and characteristics of the current co‐occurrence pattern in the prevalence of depression and obesity (C) by sub‐regions. Temporal trends of depression and obesity in isolation Temporal trends of depressive disorder varied across demographic groups. In all populations, the prevalence of depressive disorder increased significantly except in Brazil, Romania and Bosnia and Herzegovina. Among the remaining countries and territories, the largest increase was observed in the United Kingdom (AAPC: 1.82%, 95% confidence interval [CI] 1.62%–2.04%) and the smallest in Peru (0.30%, 95% CI 0.06%–0.55%). For girls, the increase was not significant in 14 countries and territories and Hungary showed a decreasing trend with an AAPC of −0.31% (95% CI −0.55% to −0.10%). For boys, AAPCs were not significant in eight countries and territories; for the rest, AAPCs ranged from 0.28% (95% CI 0.09%–0.46%) in Mongolia to 3.16% (95% CI 2.92%–3.40%) in the Maldives. Non‐significant decreases were observed among women in Australia and men in Korea and Brazil. For the remaining 198 countries and territories, AAPCs for women ranged from 0.19% (95% CI 0.03%–0.39%) in Brazil to 1.73% (95% CI 1.60%–1.90%) in Mauritius and AAPCs for men ranged from 0.23% (95% CI 0.05%–0.51%) in Romania to 1.61% (95% CI 1.40%–1.77%) in Mauritius (Supplementary figure S2A). All AAPCs are presented in Supplementary table S1. Globally, the prevalence of obesity increased significantly across all populations except in France (−0.06%, 95% CI −0.07% to −0.05%). Regional disparities in temporal trends were observed when stratified by age and sex. For girls, significant decreases occurred in Kyrgyzstan (−4.11%, 95% CI −4.14% to −4.08%), Kazakhstan (−0.38%, 95% CI −0.39% to −0.37%) and Denmark (−0.27%, 95% CI −0.30% to −0.24%). For boys, decreasing trends were also observed in Kyrgyzstan (−4.11%, 95% CI −4.14% to −4.08%) and Tajikistan (−0.16%, 95% CI −0.19% to −0.13%). For women, significant decreases were found in Spain (−0.94%, 95% CI −0.95% to −0.93%), France (−0.62%, 95% CI −0.62% to −0.61%), Lithuania (−0.18%, 95% CI −0.19% to −0.18%) and Moldova (−0.08%, 95% CI −0.08% to −0.07%). For men, however, the increase occurred in all countries and territories, with AAPCs ranging from 0.17% (95% CI 0.15%–0.18%) in France to 10.39% (95% CI 10.37%–10.42%) in Vietnam (Supplementary figure S2B). All AAPCs are presented in Supplementary table S2. Temporal trends in depression–obesity comorbidity The prevalence of depression–obesity comorbidity in 2022 ranged from 64.53 per 100 000 in East Timor to 2848.62 per 100 000 in the Syrian Arab Republic. The spatial distribution of comorbidity was characterised by higher prevalence in Oceania, the Americas, North Africa and West Asia (figure 3A and Supplementary figure S3A). This spatial distribution persisted when alternative k values were applied (Supplementary figure S8). The median global comorbidity ranged from 706.68 to 862.80 per 100 000 across all k values (Supplementary figure S9) and 171 (86%) countries and territories maintained consistent quartile groupings. Specifically, 47, 36, 40 and 48 countries and territories remained in the low, lower‐middle, upper‐middle and high quartiles, respectively. Global distribution of the current prevalence of depression–obesity comorbidity (A) and the distribution of the average annual percentage change (AAPC) of comorbidity from 1990 to 2022 (B). The temporal trend of comorbidity showed a global increase, with AAPCs ranging from 0.68% (95% CI 0.53%–0.84%) in France to 10.67% (95% CI 10.46%–10.93%) in Vietnam (Supplementary table S3). The top 10 and bottom 10 countries and territories by AAPC are presented in Supplementary figure S5. The increasing temporal trends varied by geographical area and SDI strata. Specifically, comorbidity grew faster in Asia and Africa, especially in Southeast Asia, East Asia, South Asia and sub‐Saharan Africa, but more slowly in Europe and Oceania (figure 3B and Supplementary figure S3B). Compared with low‐SDI countries and territories, AAPCs in the remaining SDI groups were lower (Supplementary figure S6A). The temporal trends of comorbidity also varied by sex and age group (Supplementary figure S6B). For girls, a decrease was observed only in Kyrgyzstan (−2.92%, 95% CI −3.20% to −2.71%), whilst increases were observed in the other 198 countries and territories, with AAPCs ranging from 0.48% (95% CI 0.22%–0.74%) in Kazakhstan to 14.42% (95% CI 14.05%–14.84%) in Vietnam. For boys, the decrease was also limited to Kyrgyzstan (−2.81%, 95% CI −3.08% to −2.59%), whilst the remaining 198 countries and territories showed increases from 1.08% (95% CI 0.80%–1.43%) in Spain to 15.84% (95% CI 15.34%–16.35%) in Vietnam. For women, a decrease occurred in Spain (−0.29%, 95% CI −0.44% to −0.14%) and the increase in France was not significant. Across 197 other countries and territories, AAPCs ranged from 0.47% (95% CI 0.30%–0.65%) in Lithuania to 10.15% (95% CI 9.96%–10.38%) in Nepal. For men, the increase occurred in all countries and territories, with AAPCs ranging from 0.78% (95% CI 0.62%–0.92%) in France to 11.54% (95% CI 11.38%–11.73%) in Vietnam. AAPCs differed significantly between girls (median AAPC: 5.60%, interquartile range [IQR]: 4.32%–6.59%) and boys (6.33%, IQR: 4.59%–8.24%) (p < 0.001), but not between adult men and women (Supplementary figure S6B). Among women and men, AAPCs in the low‐SDI group differed significantly from those in the medium‐low‐SDI, medium‐high‐SDI and high‐SDI groups. Among girls, significant differences were observed between the low‐SDI group and the medium‐high‐ and high‐SDI groups (Supplementary figure S7). Projection of depression–obesity comorbidity The ARIMA model projected that the median prevalence would increase from 833.32 (IQR: 532.07–1367.42) per 100 000 in 2030 to 869.35 (IQR: 544.11–1403.71) per 100 000 in 2035 (Supplementary table S6). The predicted prevalence of comorbidity in 2030 and 2035 showed heterogeneity across SDI and geographical groups. The highest median forecast in both 2030 and 2035 was in the middle‐SDI group (1148.29 per 100 000 for both years), whilst the low‐SDI group had the lowest median values (456.21 per 100 000 in 2030 and 492.48 per 100 000 in 2035). Geographically, Oceania had the highest regional median forecast in both 2030 and 2035 (1656.35 per 100 000 in both years) and Polynesia showed the highest projected values (2500.99 per 100 000 in both years) at the sub‐regional level (Supplementary table S6). All predicted prevalence values are presented in Supplementary table S5. Country‐level socioeconomic differences in temporal trends in depression–obesity comorbidity We categorised the 199 countries and territories into four groups based on the median of standardised AAPCs. A total of 44 (22.11%) countries and territories were classified as the double‐fast‐growing group, primarily distributed across East Asia, South Asia and sub‐Saharan Africa; the depression‐driven‐growing group consisted of 56 (28.14%) countries and territories, primarily distributed in Central Asia, West Asia, North Africa, North America and Oceania; the obesity‐driven‐growing group included 56 (28.14%) countries and territories, distributed across East Asia, South Asia, Latin America and the Caribbean; the remaining 43 (21.61%) countries and territories were categorised as the double‐slow‐growing group, primarily distributed in Europe, Australia and New Zealand (figure 4). Descriptive statistics for these four AAPC groups are presented in Supplementary table S4. Global distribution of the obesity and depression growth patterns based on the standardised AAPC quadrant distribution. (A) Patterns aggregated by major geographic regions; (B) Patterns further disaggregated by sub‑regions. AAPC, average annual percentage change. Compared with the double‐slow‐growing group, the obesity‐driven‐growing group had a lower SDI, GNI, number of hospital beds per 1000 people and a higher undernourishment rate; the depression‐driven‐growing group had a fewer hospital beds per 1000 people; and the double‐fast‐growing group had a lower SDI, GNI and number of hospital beds per 1000 people and a higher undernourishment rate (table 1). TABLE 1Differences in socioeconomic indicators across the four comorbidity growth pattern groupsComparison groupsVariableMedian difference (95% CI)Mann–Whitney U values p‐valueDouble‐slow‐growing group (n = 43) versus double‐fast‐growing group (n = 44)Female unemployment−1.18 (−2.47 to 0.25)775.500.149Male unemployment−2.01 (−3.10 to −0.41)555.500.001GINI3.25 (2.57–3.68)1483.50< 0.001Hospital beds per 1000 people−3.19 (−4.34 to −2.42)227.50< 0.001GNI−18 460.00 (−25 544.00 to −10 705.00)235.50< 0.001Undernourishment rate8.15 (3.45–13.80)1551.00< 0.001SDI−0.27 (−0.32 to −0.19)232.00< 0.001Double‐slow‐growing group (n = 43) versus depression‐driven‐growing group (n = 56)Female unemployment−0.25 (−1.27 to 1.23)1293.500.529Male unemployment−0.94 (−1.95 to 0.40)1056.500.299GINI0 (−0.68 to 0.85)1266.000.659Hospital beds per 1000 people−1.64 (−2.08 to −0.71)666.00< 0.001GNI−7953.00 (−18 810.00 to 4897.00)996.500.144Undernourishment rate0.65 (0.00 to 3.09)1466.500.040SDI−0.07 (−0.11 to −0.01)934.000.057Double‐slow‐growing group (n = 43) versus obesity‐driven‐growing group (n = 56)Female unemployment−0.25 (−1.68 to 0.83)1191.000.930Male unemployment−1.92 (−2.85 to −0.17)834.000.009GINI3.49 (2.73–5.75)1804.50< 0.001Hospital beds per 1000 people−2.86 (−4.01 to −1.82)504.00< 0.001GNI−16 350.00 (−23 933.00 to −8340.00)412.00< 0.001Undernourishment rate5.40 (2.80–10.80)1886.00< 0.001SDI−0.19 (−0.29 to −0.12)310.00< 0.001 Note: The 95% CI for the median difference was calculated using a bootstrap approach.Abbreviations: CI, confidence interval; GINI, Gini index; GNI, gross national income per capita; SDI, Socio‐Demographic Index. Differences in socioeconomic indicators across the four comorbidity growth pattern groups Note: The 95% CI for the median difference was calculated using a bootstrap approach. Abbreviations: CI, confidence interval; GINI, Gini index; GNI, gross national income per capita; SDI, Socio‐Demographic Index. DISCUSSION Main findings In this study, we characterised the global co‐occurrence patterns, temporal trends and socioeconomic correlates of depression and obesity across 199 countries and territories. First, co‐occurrence patterns showed geographical variation. The consistently‐low‐prevalence group was primarily concentrated in Central, East and Southeast Asia, whilst the consistently‐high‐prevalence group was in West Asia, North Africa and North America. The obesity‐dominant group was concentrated in North America, Eastern Europe, Oceania and Latin America and the Caribbean, whilst the depression‐dominant group was in South Asia, Western Europe and sub‐Saharan Africa. Second, the comorbidity has been rising globally since 1990, but with regional heterogeneity in growth patterns. Countries and territories in Southeast Asia, East Asia, South Asia and sub‐Saharan Africa were classified into the double‐fast‐growing group, whilst the double‐slow‐growing group was primarily distributed in Europe, Australia and New Zealand. East Asia, South Asia, sub‐Saharan Africa and Latin America and the Caribbean showed an obesity‐driven increasing trend, whereas Central Asia, West Asia, North Africa, North America and Oceania showed a depression‐driven increasing trend. Notably, most countries and territories in East Asia, Southeast Asia and sub‐Saharan Africa had a comorbidity prevalence below the global 25th percentile, yet their temporal trends were above the 75th percentile. Conversely, most countries and territories in North America, Europe and Oceania had comorbidity prevalence above the 75th percentile despite temporal trends below the 25th percentile. Additionally, the ARIMA model projected that both the global mean and median prevalence would increase from 2030 to 2035, with variation across SDI and geographical groups. The middle‐SDI group and Oceania had the highest median predicted prevalence in 2030 and 2035. Finally, we found country‐level socioeconomic differences across the comorbidity growth pattern groups. Specifically, countries and territories with slower growth in both obesity and depression (the double‐slow‐growing group) had higher SDI, GNI and hospital beds per 1000 people, as well as lower GINI and undernourishment rates. The observed co‐occurrence patterns and temporal trends of depression and obesity may be explained as follows. First, depression‐driven progression to obesity through unhealthy behaviours may account for the depression‐driven pattern observed in the consistently‐high‐prevalence regions (West Asia, North Africa and North America). Depression may progress to obesity and subsequent comorbidity through emotional overeating and insufficient sleep. 50 Previous studies corroborate these findings, showing that depression is increasing in these regions due to socioeconomic pressures, high living costs, 51 , 52 limited community‐based psychosocial services and psychiatric stigma. 53 Second, obesity‐driven depression, mediated by biological and socio‐behavioural mechanisms, may account for the obesity‐dominant pattern observed in Latin America and the Caribbean. Biologically, changes in the hypothalamic–pituitary–adrenal axis, systemic inflammation and gut microbiome in individuals with obesity may impair emotional regulation, increasing the risk of depression. 54 , 55 Socio‐behaviourally, individuals with obesity may experience weight‐related stigma. Weight‐related stigma could increase the risk of depression and weight gain, 56 and studies have reported rising obesity prevalence 57 and widespread weight‐related stigma 58 in Latin America and the Caribbean. Lastly, shared risk factors for obesity and depression may account for the epidemiological trend findings in East and Southeast Asia, where current prevalence was low but growth was rapid (the double‐fast‐growing pattern). Chronic stress and reduced physical activity are common risk factors for both obesity and depression. In East and Southeast Asia, intense educational and job competition, limited time for outdoor physical activity and sedentary lifestyles are becoming increasingly common among younger generations, 59 contributing to a rapid increase in obesity and depression. 60 , 61 This study also highlighted the importance of country‐level socioeconomic conditions. Country‐level socioeconomic conditions, including unhealthy food environments, poor mental healthcare and low economic development, may create a risk context for the rising prevalence of obesity, depression and their comorbidity. Unhealthy food environments, such as high ultra‐processed food exposure and excessive sugar intake, are not only associated with obesity directly but may also alter neurobiological function in individuals with obesity, placing them at higher risk of depression. 62 , 63 , 64 , 65 , 66 Poor mental healthcare constrains the capacity to treat and manage depression, 67 , 68 increasing the risk that untreated depression progresses to comorbidity. Poor economic conditions are associated with a shortage of nutritionists, limited opportunities for physical activity and broader social inequalities (e.g., unemployment, weak social support and adverse early‐life circumstances), all of which have been linked to depression–obesity comorbidity. 69 , 70 , 71 , 72 , 73 Beyond the regional heterogeneity and socioeconomic differences, our study observed that the prevalence of depression–obesity comorbidity among children and adolescents has also increased since 1990. This finding may be explained by two factors: physiological development and social environment. Regarding physiological development, immature prefrontal function and hyperactivation of the hypothalamic–pituitary–adrenal axis may contribute to depression–obesity comorbidity. 54 , 74 Dysfunction of physiological mechanisms increases susceptibility to negative emotions (e.g., stress, depression) and disordered eating behaviours (e.g., emotional overeating, preference for energy‐dense food) in children and adolescents. Regarding the social environment, excessive social media use by children and adolescents not only contributes to unhealthy behaviours, including excess screen time, insufficient sleep and lack of physical activity, but also hampers emotional regulation and social coping skills. 75 Limitations We acknowledge several limitations in this study. First, this was an eco‐epidemiological study that may be subject to ecological fallacies, and differences among the temporal trend groups cannot be used to infer individual‐level causal relationships. However, the primary objective of this study was to describe similarities and differences in socioeconomic contexts at the country level rather than to infer aetiological associations at the individual level. This country‐level description may help inform regionally accessible and culturally appropriate measures to address obesity and depression. Second, the formula used to estimate comorbidity is a simplified model, as it does not fully account for the non‐linear characteristics and complex interactions between obesity and depression. Nevertheless, our estimates provide valuable public health insights into the increasing trend of depression–obesity comorbidity at the global scale, especially considering the lack of global data on this critical issue. Building on this study, we suggest that future studies examine the epidemiological trends of depression–obesity comorbidity in addition to trends of each condition in isolation. Moreover, our estimation of comorbidity was consistent with previous epidemiological studies analysing obesity and depression separately. 27 , 60 , 61 , 76 , 77 Third, we did not model regressions for subgroups and influences because of the covariance of the independent variables, but the bootstrap approach was a superior statistical method for the comparison of non‐normal data with differing variances. 78 The socioeconomic characteristics of the obesity and depression patterns were also consistent with previous findings. 77 Fourth, inconsistent availability of primary epidemiological data on depression and obesity is a limitation common to all global analyses. However, this limitation was minimised by the robust data processing methods employed in the GBD and NCD‐RisC and their statistical models have been shown to be unbiased with small deviations. 27 , 79 Fifth, the categorisation of growth patterns was based on AAPCs in this study. AAPCs represent relative rather than absolute increases and baseline prevalence levels must be considered when interpreting them. Thus, this growth may reflect small absolute changes rather than meaningful epidemiological trends. However, grouping countries and territories into different growth patterns based on AAPCs remains meaningful for public health early warning. Implications Depression–obesity comorbidity has become increasingly prevalent, and both co‐occurrence and growth patterns vary by region and socioeconomic context. Our predictive analysis indicated that depression–obesity comorbidity may continue to increase. Therefore, policymakers should prioritise the implementation of accessible and culturally appropriate measures to reduce weight and mental illness stigma and to create healthier food, mental healthcare and physical activity environments. Globally, there is a need to address both weight and mental illness stigma by enacting anti‐discrimination laws and adopting stigma reduction strategies in healthcare practices. 74 , 75 , 80 , 81 For obesity‐driven regions (e.g., Latin America), food environment regulations such as sugar taxes and nutrition education may be beneficial and feasible. 82 , 83 For depression‐driven regions (e.g., West Asia), expanding access to community‐based mental health services is a promising approach to treating and managing depression more effectively, thereby mitigating the downstream risk of comorbidity. 84 For double‐fast‐growing regions (e.g., Southeast Asia), governments need to pay attention to the common risk factors for obesity and depression, including stress, unhealthy dietary habits, sedentary behaviours and reduced physical activity. 85 Given the inverse relationship between comorbidity prevalence and temporal trends in some regions, we call for differentiated public health strategies. Regions with low prevalence but rapid growth (e.g., East Asia, Southeast Asia and sub‐Saharan Africa) require proactive preventive measures to curb the rising prevalence. Conversely, regions with high prevalence but slower growth, such as North America, demand sustained focus on treatment access and mitigating the drivers of comorbidity persistence. Given the rising prevalence of comorbidity among children and adolescents, there is an urgent need for targeted interventions at both the individual level (e.g., cognitive–emotional training) and the societal level (e.g., limiting social media use). CONCLUSION This global study indicated an accelerated increase in depression–obesity comorbidity in low‐SDI settings. There were distinct differences among growth patterns: obesity‐driven growth in East Asia, South Asia, Latin America and the Caribbean was associated with fewer hospital beds per 1000 people, lower SDI and higher undernourishment; depression‐driven growth in Central and West Asia co‐occurred with health infrastructure deficits (fewer hospital beds per 1000 people); and double‐fast growth across 44 vulnerable countries and territories was evident in settings marked by structural inequities (lower SDI and GNI but higher undernourishment). This study highlighted structural inequalities in the comorbidity patterns, temporal trends and risk factors of depression–obesity comorbidity, which demand urgent multisectoral action: (1) integrating nutrition–mental health services in rapid‐growth regions, (2) strengthening health infrastructure in low‐resource settings and (3) implementing gender‐responsive policies targeting unemployment–comorbidity links. Future research should employ implementation science frameworks to develop context‐specific interventions addressing these geographically patterned determinants. AUTHOR CONTRIBUTIONS Zheng Liu conceived and designed the research. Yang Yang, Jingqi Kong, and Zheng Liu drafted the manuscript. Yang Yang, Jingqi Kong, Jing Chen, Yihang Yang, Jingyao Liu, and Runze Hu analysed the data. Zheng Liu critically revised the manuscript. All authors read, critically revised, and approved the final version of the manuscript. Zheng Liu is the guarantor of this work. FUNDING This work was supported by the National Natural Science Foundation of China (82373694), the Beijing Municipal Natural Science Foundation (7262165), Young Elite Scientists Sponsorship Program by CAST (2023QNRC001) and Beijing Education Sciences Planning Program during the 14th Five‐Year Plan (BECA23111). CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. ETHICS STATEMENT Not applicable. PATIENT CONSENT FOR PUBLICATION Not applicable. Supporting information Supporting Information S1 ACKNOWLEDGEMENTS We express sincere gratitude to the Global Burden of Disease Database, NCD Risk Factor Collaboration and World Bank Open Data for their valuable data. These data made it possible to estimate the trends of depressive disorders, obesity and their comorbidity in 199 countries and territories and to explore the risk factors for their growth patterns. Biography Yang Yang is currently a master's student in maternal and child health at the Department of Maternal and Child Health, School of Public Health, Peking University, China. She received her bachelor's degree in preventive medicine from the School of Public Health, Zhengzhou University, China. Her main research interests include the promotion of physical and mental health in children and adolescents. DATA AVAILABILITY STATEMENT The data supporting the findings of this study were derived from the following publicly available resources: Global Burden of Disease Study 2023 (http://ghdx.healthdata.org/gbd‐2023); NCD Risk Factor Collaboration (NCD‐RisC) (https://ncdrisc.org); World Bank Open Data (https://data.worldbank.org). All analytical methods and code are available from the corresponding author upon reasonable request. REFERENCES Associated Data Supplementary Materials Supporting Information S1 Data Availability Statement The data supporting the findings of this study were derived from the following publicly available resources: Global Burden of Disease Study 2023 (http://ghdx.healthdata.org/gbd‐2023); NCD Risk Factor Collaboration (NCD‐RisC) (https://ncdrisc.org); World Bank Open Data (https://data.worldbank.org). All analytical methods and code are available from the corresponding author upon reasonable request.